Results 81 to 90 of about 3,938,816 (209)

Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent [PDF]

open access: yes, 2017
This paper reports the MEPS-HPLC-DAD method for the simultaneous determination of 12 azole drugs (bifonazole, butoconazole, clotrimazole, econazole, itraconazole, ketoconazole, miconazole, posaconazole, ravuconazole, terconazole, tioconazole and ...
Campestre, Cristina   +9 more
core   +1 more source

Exploring the Molecular Basis of Antifungal Synergies Using Genome-Wide Approaches

open access: yesFrontiers in Microbiology, 2012
Drug resistance poses a significant challenge in antifungal therapy since resistance has been found for all known classes of antifungal drugs. The discovery of compounds that can act synergistically with antifungal drugs is an important strategy to ...
Ameeta eAgarwal   +6 more
doaj   +1 more source

In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates

open access: yesAntimicrobial Agents and Chemotherapy, 2018
FK506 (tacrolimus) is an FDA-approved immunosuppressant indicated for the prevention of allograft rejections in patients undergoing organ transplants.
Yeonseon Lee   +13 more
semanticscholar   +1 more source

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease. [PDF]

open access: yes, 2017
F901318 is an antifungal agent with a novel mechanism of action and potent activity against Aspergillus spp. An understanding of the pharmacodynamics (PD) of F901318 is required for selection of effective regimens for study in phase II and III clinical ...
Adam Johnson   +12 more
core   +2 more sources

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis. [PDF]

open access: yes, 2019
Invasive pulmonary aspergillosis (IPA) due to Aspergillus fumigatus is a serious fungal infection in the immunosuppressed patient population. Despite the introduction of new antifungal agents, mortality rates remain high, and new treatments are needed ...
Alkhazraji, Sondus   +7 more
core  

Adhesive Properties and Sensitivity to Antifungal Drugs of Candida Albicans, Which Are Released From Patients of Gastroenterological Profile with Candidiasis of the Mucosa of the Upper Part of the Digestive Tract [PDF]

open access: yes, 2016
Candida albicans were released from 146 loci from 89 patients in order to perform the investigation. The fourth stage of contamination by Candida albicans in the scrape from the tongue and candidiasis of the esophagus or /and the stomach during ...
Kushnirenko, I. (Inessa)
core   +2 more sources

Targeting Candida albicans filamentation for antifungal drug development

open access: yesVirulence, 2017
Candida albicans remains the main etiological agent of candidiasis, as this otherwise normal commensal of humans is capable of causing active infection in immune- and medically-compromised patients.
T. Vila   +5 more
semanticscholar   +1 more source

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens. [PDF]

open access: yes, 2017
The fast development of multi-drug resistant (MDR) organisms increasingly threatens global health and well-being. Plant natural products have been known for centuries as alternative medicines that can possess pharmacological characteristics, including ...
Alsaadi, Abrar I   +6 more
core   +2 more sources

Antifungal Drug Susceptibility Testing of Dermatophytes: Laboratory Findings to Clinical Implications

open access: yesIndian Dermatology Online Journal, 2019
© 2019 Indian Dermatology Online Journal | Published by Wolters Kluwer Medknow Dermatophytes are the most commonly encountered fungi in humans and other vertebrates that spread through direct contact with infected humans, animals, and soil.[1] Infections
S. Dogra, Dipika Shaw, S. Rudramurthy
semanticscholar   +1 more source

Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]

open access: yes, 2016
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy